20th May 2009 1:46 pm |
BUS |
Pfizer Expands Its Generics Portfolio Through Innovative Licensing Deals, Increasing Access To Medicines For Billions Worldwide |
20th May 2009 7:00 am |
BUS |
Addition of Lyrica Significantly Improved Generalized Anxiety Disorder Symptoms in Patients Who Responded Only Partially to Previous GAD Treatments |
14th May 2009 1:34 pm |
BUS |
Pfizer Launches Free Medicines Program For Newly Unemployed Americans |
13th May 2009 5:30 pm |
BUS |
Pfizer to Present New Clinical Data Highlighting Customized Treatment Approaches For Difficult-To-Treat Cancers |
12th May 2009 2:30 pm |
BUS |
Greg Simon, Noted Leader In Health And Science Policy, Joins Pfizer |
5th May 2009 7:00 am |
BUS |
Dr. Freda Lewis-Hall Joins Pfizer As Chief Medical Officer |
30th Apr 2009 7:00 am |
BUS |
Lyrica Significantly Reduced Pain and Improved Other Symptoms of Post-Traumatic Peripheral Nerve Pain, New Data Show |
28th Apr 2009 12:00 pm |
BUS |
Pfizer Reports First-Quarter 2009 Results; Reaffirms Full-Year 2009 Financial Guidance for Revenues and Adjusted Results(1) |
24th Apr 2009 8:00 am |
BUS |
Pfizer And University College London Announce Collaboration To Advance Development Of Stem Cell-Based Therapies |
23rd Apr 2009 3:38 pm |
BUS |
Pfizer Hosts Annual Meeting Of Shareholders; Declares A 16-Cent Second-Quarter 2009 Dividend |
22nd Apr 2009 4:00 pm |
BUS |
Pfizer and Medicines for Malaria Venture Advancing International Research Efforts in the Fight against Malaria |
16th Apr 2009 11:00 am |
RNS |
GSK Specialist HIV Company |
7th Apr 2009 2:10 pm |
BUS |
Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquisition |
6th Apr 2009 7:00 am |
BUS |
Pfizer Receives Request for Additional Information from FTC Regarding Proposed Acquisition of Wyeth |
3rd Apr 2009 5:36 pm |
BUS |
Pfizer Becomes The First Pharmaceutical Company To Be Accredited For Protection Of Human Rights In Clinical Research |
2nd Apr 2009 5:02 pm |
BUS |
Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas |
2nd Apr 2009 1:29 pm |
BUS |
Pfizer Discontinues One Sunitinib Phase 3 Trial in Advanced Breast Cancer; Other Advanced Breast Cancer Trials Continue |
31st Mar 2009 2:01 pm |
BUS |
Significantly More Patients With Cardiovascular Disease Quit Smoking Using Chantix/Champix(®) (Varenicline) Compared With Placebo |
31st Mar 2009 7:00 am |
BUS |
Intensive Lipitor Therapy Provided Sustained Risk Reduction Of Cardiovascular Events In Older Patients With Heart Disease |
25th Mar 2009 12:30 pm |
BUS |
Pfizer Announces Completion of $13.5 Billion Debt Offering |
23rd Mar 2009 2:03 pm |
BUS |
Pfizer's Oncology Business Unit Appoints Senior Executive to Head U.S. Region |
20th Mar 2009 9:00 am |
BUS |
Pfizer, PlaNet Finance Partner to Study Options for Expanding Access to Healthcare in China |
19th Mar 2009 11:10 am |
BUS |
Pfizer-Sponsored Prescription Savings Program - Together Rx Access® - Expands Eligibility Criteria in Response to Challenging Economic Times |
17th Mar 2009 12:30 pm |
BUS |
U.S. Patent & Trademark Office Grants Reissue Patent Relating to Lipitor |
13th Mar 2009 7:00 am |
BUS |
Wide-Reaching Global Survey Reveals Majority of Women Living with Metastatic Breast Cancer Desire Increased Public Attention |
12th Mar 2009 12:29 pm |
BUS |
Sutent Significantly Increases Progression Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors, Study Stopped Early |
3rd Mar 2009 1:25 pm |
BUS |
Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions |
3rd Mar 2009 8:30 am |
BUS |
Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe Through Licensing Agreements with Aurobindo |
24th Feb 2009 1:39 pm |
BUS |
Pfizer Discontinues Development of Two Phase 3 Compounds |
10th Feb 2009 7:00 am |
BUS |
Pfizer to Publicly Disclose Payments to U.S. Physicians, Healthcare Professionals and Clinical Investigators |
4th Feb 2009 5:09 pm |
BUS |
Pfizer and The Pfizer Foundation Recognize "World Cancer Day" Award $7 Million in Grants to Support Global Cancer Control Efforts |
4th Feb 2009 7:00 am |
BUS |
Pfizer's Sutent is Recommended as First-Line Treatment for Kidney Cancer Patients by British Health Agency |
2nd Feb 2009 1:47 pm |
BUS |
Lipitor Significantly Reduced hsCRP Levels in Patients with Stable Coronary Artery Disease, According to New Study |
2nd Feb 2009 7:00 am |
BUS |
Pfizer Discontinues Global Phase III Trial of Axitinib for Futility in Advanced Pancreatic Cancer |
27th Jan 2009 4:37 pm |
BUS |
Pfizer Invites Public to Listen to Audio-Only Webcast of January 27 Investor Luncheon |
26th Jan 2009 11:35 am |
BUS |
MEDIA ADVISORY: Pfizer and Wyeth to Host Live Press Conference in New York |
26th Jan 2009 11:29 am |
BUS |
Pfizer Reports Fourth-Quarter and Full-Year 2008 Results and 2009 Financial Guidance |
26th Jan 2009 11:27 am |
BUS |
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company |
19th Jan 2009 7:00 am |
BUS |
Pfizer Receives FDA Complete Response Letter for Lasofoxifene |
14th Jan 2009 1:33 pm |
BUS |
Stephen W. Sanger Elected to Pfizer's Board of Directors |